Surgical Science (Sweden) Insiders
| SUS Stock | SEK 157.50 1.50 0.94% |
Surgical Science employs about 233 people. The company is managed by 10 executives with a total tenure of roughly 544 years, averaging almost 54.0 years of service per executive, having 23.3 employees per reported executive. Breaking down Surgical Science's management performance can provide insight into the firm performance.
| Inbal MazorBadichi Insider VP Marketing |
| Ran Bronstein Insider Pres RD |
Surgical |
Surgical Science Management Team Effectiveness
The company has return on total asset (ROA) of 0.0212 % which means that it generated a profit of $0.0212 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0357 %, meaning that it generated $0.0357 on every $100 dollars invested by stockholders. Surgical Science's management efficiency ratios could be used to measure how well Surgical Science manages its routine affairs as well as how well it operates its assets and liabilities.Surgical Science Workforce Comparison
Surgical Science Sweden is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Information Services industry is at this time estimated at about 3,751. Surgical Science holds roughly 233 in number of employees claiming about 6% of equities under Health Information Services industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Surgical Science Sweden Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Surgical Science Sweden Price Series Summation is a cross summation of Surgical Science price series and its benchmark/peer.
Surgical Science Notable Stakeholders
A Surgical Science stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Surgical Science often face trade-offs trying to please all of them. Surgical Science's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Surgical Science's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Inbal MazorBadichi | VP Marketing | Profile | |
| Ran Bronstein | Pres RD | Profile | |
| Anna Ahlberg | Chief Officer | Profile | |
| Adv | Chief Officer | Profile | |
| Daniel Evestedt | Head Devel | Profile | |
| Jeffrey Berkley | Chief Officer | Profile | |
| Martin Jansson | Head Sales | Profile | |
| Anders Larsson | CoFounder CTO | Profile | |
| Gisli Hennermark | Chief Officer | Profile | |
| Doron Zilberman | VP Sales | Profile |
About Surgical Science Management Performance
The success or failure of an entity such as Surgical Science Sweden often depends on how effective the management is. Surgical Science management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Surgical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Surgical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in Surgical Science's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgical Science Sweden. Check Surgical Science's Beneish M Score to see the likelihood of Surgical Science's management manipulating its earnings.
Surgical Science Workforce Analysis
Traditionally, organizations such as Surgical Science use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Surgical Science within its industry.Surgical Science Manpower Efficiency
Return on Surgical Science Manpower
| Revenue Per Employee | 1.6M | |
| Revenue Per Executive | 36.7M | |
| Net Income Per Employee | 370.2K | |
| Net Income Per Executive | 8.6M |
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.